← All indications
Radiculopathy
Disease involving a spinal nerve root (see SPINAL NERVE ROOTS) which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.
Drugs by status
Approved for this indication (2)
Phase 4 trials (14)
Phase 3 trials (12)
Phase 2 trials (15)
Phase 1 trials (5)
Organizations
Organization Involved with Phase 4 Indications (18)
- Pfizer
- Huazhong University of Science and Technology
- Changhai Hospital
- Northwestern University
- Shanghai University of Traditional Chinese Medicine
- Singapore General Hospital
- Fudan University
- Tel Aviv University
- University of Cincinnati
- University of Utah
- Vanderbilt University
- Jiao Tong University
- Shanghai University
- St Joseph University of Beirut
- University of Paris
- Yeshiva University
- Virtua Health, Inc.
- Epimed
Organization Involved with Phase 3 Indications (20)
- Celgene
- Bausch Health Companies
- United States Army
- United States Navy
- Harvard University
- Horizon Health Network
- Jaseng Hospital of Korean Medicine
- Johns Hopkins University
- Kyung Hee University
- Worldwide Clinical Trials
- Lotus Clinical Research
- Rush University
- Canada East Spine Center
- Landstuhl Regional Medical Center
- Dongguk University
- Semnur Pharmaceuticals, Inc.
- Daegu Haany University
- Sollis Therapeutics, Inc.
- Stem Cures
- Pauza, Kevin, MD
Organization Involved with Phase 2 Indications (17)
- Convergence Pharmaceuticals
- Biogen
- GlaxoSmithKline
- TissueGene, Inc.
- Renovis
- National Institute of Dental and Craniofacial Research (NIDCR)
- University of Manitoba
- Duke University
- Assiut University
- Ruhr University Bochum
- Bragee Medect AB, Stockholm, Sweden
- Zalicus
- Medtronic
- Changchun University of Chinese Medicine
- Lanzhou Hospital of Traditional Chinese Medicine
- Suzhou Hospital of Traditional Chinese Medicine
- SpineThera, Inc.
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (18)
- National Center for Research Resources (NCRR)
- Case Western Reserve University
- Marmara University
- Navamindradhiraj University
- Tufts University
- Yonsei University
- Mayo Clinic
- Peking University
- State University of New York
- Taipei Medical University
- Leiden University
- University of Missouri
- Pennsylvania State University
- State University of New York, Syracuse
- Department of Veteran Affairs
- Spaarne Gasthuis
- Achmea Healthcare Foundation
- Posthumus Meyjes Fonds